主页 > 医学信息 >

【文摘发布】T-SPOT.TB和QuantiFERON-TB诊断结核的临床

Title: Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study.

Author: Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, Meccugni B, Dori IM, Andreani A, Bergamini BM, Mussini C, Rumpianesi F, Fabbri LM, Richeldi L.

Resourse :Lancet. 2006 Apr 22;367(9519):1328-34.

BACKGROUND: Two commercial blood assays for the diagnosis of latent tuberculosis infection--T-SPOT.TB and QuantiFERON-TB Gold--have been separately compared with the tuberculin skin test. Our aim was to compare the efficacy of all three tests in the same population sample. METHODS: We did a prospective study in 393 consecutively enrolled patients who were tested simultaneously with T-SPOT.TB and QuantiFERON-TB Gold because of suspected latent or active tuberculosis. 318 patients also had results available for a tuberculin skin test. FINDINGS: Overall agreement with the skin test was similar (T-SPOT.TB kappa=0.508, QuantiFERON-TB Gold kappa=0.460), but fewer BCG-vaccinated individuals were identified as positive by the two blood assays than by the tuberculin skin test (p=0.003 for T-SPOT.TB and p<0.0001 for QuantiFERON-TB Gold). Indeterminate results were significantly more frequent with QuantiFERON-TB Gold (11%, 43 of 383) than with T-SPOT.TB (3%, 12 of 383; p<0.0001) and were associated with immunosuppressive treatments for both tests. Age younger than 5 years was significantly associated with indeterminate results with QuantiFERON-TB Gold (p=0.003), but not with T-SPOT.TB. Overall, T-SPOT.TB produced significantly more positive results (38%, n=144, vs 26%, n=100, with QuantiFERON-TB Gold; p<0.0001), and close contacts of patients with active tuberculosis were more likely to be positive with T-SPOT.TB than with QuantiFERON-TB Gold (p=0.0010). INTERPRETATION: T-SPOT.TB and QuantiFERON-TB Gold have higher specificity than the tuberculin skin test. Rates of indeterminate and positive results, however, differ between the blood tests, suggesting that they might provide different results in routine clinical practice.

PMID: 16631911 本人已认领该文编译,48小时后若未提交译文,请其他战友自由认领。 Title: Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study.
标题:用来检测结核分支杆菌传染病的诊断的两种商业化验血的日常临床实践:一种前瞻性研究。 请按新闻格式编译,详见置顶帖。 已修改,初来乍到,还需前辈多多指点,谢谢! 已修改,初来乍到,还需前辈多多指点,谢谢! [标签:content1][标签:content2]

阅读本文的人还阅读:

【drug-news】Onyx 制药肺癌

脾占位性病变的诊断和治

【drug-news】Vytorin临床对

【科普】抗药性肺结核:

【文摘发布】肿瘤血管破

作者:admin@医学,生命科学    2011-06-01 17:11
医学,生命科学网